DNA Diagnostics Market Size and Growth Forecast for Businesses 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The DNA Diagnostics Market?

The dna diagnostics market has experienced rapid expansion in recent years. This market is projected to grow from $23.1 billion in 2024 to $25.62 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.9%. The historical increase can be attributed to several factors, including the rising demand for personalized medicine, the increasing adoption of genetic testing and molecular diagnostics in clinical practice, an uptick in biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests.

The dna diagnostics market is projected to experience substantial expansion in the coming years. It is forecasted to reach ” $37.35 billion by 2029, with a compound annual growth rate (CAGR) of 9.9%. This growth during the forecast period is propelled by factors such as the increasing prevalence of cancers, a rising demand for standardized diagnostic tests, the growing occurrence of genetic disorders, a heightened focus on biomarker discovery, advancements in rare diseases and orphan drugs, and the expansion of telemedicine and remote testing. Key trends for the forecast timeframe encompass the integration of microbiome analysis, the adoption of blockchain technology, the convergence of multiple omics data, non-invasive testing, integrated multi-omics approaches, the development of portable and point-of-care DNA diagnostic devices, and the widespread use of next-generation sequencing (NGS).

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15356&type=smp

What Are The Key Drivers Of Growth In The DNA Diagnostics Market?

The increasing occurrence of genetic conditions is anticipated to drive the expansion of the DNA diagnostics market in the future. These disorders are defined as health issues stemming from one or multiple genomic irregularities. The growing number of genetic disorder cases can be attributed to enhanced diagnostic capacities, broadened genetic testing, environmental factors, and consanguineous relationships within communities, resulting in improved comprehension and identification of these conditions. Through the analysis of genetic material, DNA diagnostics allows for accurate identification of genetic disorders, thereby aiding in prompt diagnosis, tailored treatment plans, and well-informed family planning choices. As an example, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations dedicated to international public health, reported in February 2023 that congenital diseases were responsible for approximately 240,000 infant fatalities worldwide within 28 days of birth annually. Furthermore, congenital diseases account for an additional 170,000 deaths each year among children aged 1 month to 5 years. Consequently, the escalating incidence of genetic disorders is fueling the expansion of the DNA diagnostics market.

What Are The Key Segments In The DNA Diagnostics Market?

The dna diagnosticsmarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents; Software And Services

2) By Technology: Polymerase Chain Reaction; Microarray; In-situ Hybridization; Sequencing Technology; Mass Spectrometry

3) By Application: Oncology; Infectious Diseases Treatment; Myogenic Disorder Treatment; Clinical Diagnostic Confirmation; Prenatal; Pre-Implantation; Other Applications

4) By End User: Point Of Care; Diagnostic Centers; Self-Testing Or Over-The-Counter (OTC)

Subsegments:

1) By Instruments: DNA Analyzers; PCR Machines (Polymerase Chain Reaction); Sequencers (Next-Generation Sequencing, Sanger Sequencing); Electrophoresis Systems; Gene Expression Analyzers; Microarray Systems; Flow Cytometers; Spectrophotometers

2) By Reagents: PCR Reagents; DNA Extraction Kits; Sequencing Reagents; Antibodies For DNADetection; Fluorescent Dyes And Probes; Chemicals For Nucleic Acid Purification; Buffer Solutions For DNA Analysis; Hybridization And Amplification Kits

3) By Software: DNA Data Analysis Software; Bioinformatics Platforms; Genomics Software For Sequencing Data; Laboratory Information Management Systems (LIMS); Data Visualization Tools; Genetic Variant Analysis Software; Genome Mapping Software

4) By Services: Genetic Testing Services; DNA Sequencing Services; Bioinformatics Consulting And Analysis; Clinical Diagnostic Services; Genetic Counseling Services; Custom DNA Diagnostics Services; Research And Development Services

Which Key Trends Are Expected To Influence The DNA Diagnostics Market In The Coming Years?

Leading companies in the DNA diagnostics market are concentrating on developing innovative products, such as liquid biopsy tests, to identify various types of cancer in their early stages. A liquid biopsy is a medical test that is minimally invasive, detecting and analyzing biomarkers like circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes, which are released into the bloodstream from tumors or other cells. For instance, in May 2023, Laboratory Corporation, a US-based healthcare diagnostics company, introduced a new liquid biopsy test named LabCorp Plasma Focus, which helps in identifying targeted therapies for patients with advanced or metastatic solid tumors. This test uses genetic sequencing to evaluate circulating cell-free DNA (cfDNA) released by tumor cells, thereby allowing oncologists to personalize and enhance patient care through targeted therapy plans.

Who Are The Major Companies Operating In The DNA Diagnostics Market?

Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

How Does The DNA Diagnostics Market Perform Across Key Geographic Regions?

North America was the largest region in the DNA diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The DNA Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15356&type=smp

Browse Through More Reports Similar to the Global DNA Diagnostics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Recombinant Dna Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Prenatal Dna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795